MEDIA STATEMENT
bioMérieux Strengthens Its Quality Control Offering in Advanced Therapy Medicinal Products (ATMP)
Marcy-l'Étoile, France and San Jose, California, May 6th, 2021 - bioMérieux is designated as the exclusive distributor of Accellix products in China, Japan, Australia and South Korea. Under the agreement signed on February 18th, 2021, bioMérieux will perform the full range of sales, supply and service activities in the Asia Pacific region. The Accellix technology enables complex cellular quality control (QC) testing of cellular therapies, at the point of manufacturing from starting material to final product.